Trade Mark Journal No.2026/029 17 July 2026

WO0000001925791 (5,10,42)

Office of origin: France

Date of International Registration:13 March 2026
Date of designation in the UK: 13 March 2026
Image for mark 1925791 VIASKIN

International priority date claimed: 9 March 2026 (France) (5235530)
Class 5
Transdermal patches; skin patches and adhesive skin patches for medical use; transdermal patches and adhesive skin patches for treating, relieving or preventing the development or progression of allergies or immunological disorders; transdermal patches and adhesive skin patches for transdermal administration of pharmaceuticals or medical preparations; epicutaneous patches or swabs for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or epicutaneous adhesive swabs for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or epicutaneous occlusive swabs for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; epicutaneous patches or swabs containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders; epicutaneous patches or swabs for treating allergies or immunological disorders; epicutaneous patches or pads containing allergens or antigens for treating allergies or immunological disorders; medicines against allergies; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; parts and accessories of the aforesaid goods.
Class 10
Medical devices, apparatus and instruments for cutaneous or epicutaneous administration or delivery, or administration or delivery via a patch, of medical or pharmaceutical substances for the treatment, relief or prevention of allergies or immunological disorders; medical instruments for training, namely, non-medicated skin patches and swabs sold without medication for receiving, maintaining or containing medical or pharmaceutical substances for treatment, relief or prevention of allergies or immunological disorders; medical instruments for training, namely, non-medicated skin patches and swabs sold without medication for use in medical training; medical instruments for training, namely, non-medicated skin patches and swabs for medical use sold without medication, namely, for use in training healthcare professionals on transdermal administration of pharmaceutical products or medical preparations; medical devices, apparatus and instruments sold without medication for the subsequent cutaneous or epicutaneous administration of medical or pharmaceutical substances; dispensers and applicators for swabs, skin patches, and occlusive patches for medical use; parts and accessories of the aforesaid goods.
Class 42
Medical and scientific research services in the field of allergies and immunotherapy; development of scientific methods for cutaneous and epicutaneous immunotherapy; medical and scientific research relating to the treatment, relief and prevention of autoimmune, infectious and inflammatory diseases; medical and scientific research in the fields of allergy treatment and care; allergen drug research services; medical and scientific research services, namely development of methods for treating allergies via contact between allergens and the skin; medical and scientific research services, namely development of methods for treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to the skin of patients; information, advisory and consultancy services relating to the aforementioned services.

DBV TECHNOLOGIES

Representative: PAIRAULT Annick AB INITIO, 22 Rue La Fayette, F-75009 Paris, FRANCE